These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4602527)

  • 1. The development of a heterologous transfusion technique: application to sickle cell disease.
    Finch SC; Castro O; Orlin J; Rosen MW; Aponte L
    Conn Med; 1974 Jul; 38(7):338-41. PubMed ID: 4602527
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion-reversible functional asplenia in young children with sickle-cell anemia.
    Pearson HA; Cornelius EA; Schwartz AD; Zelson JH; Wolfson SL; Spencer RP
    N Engl J Med; 1970 Aug; 283(7):334-7. PubMed ID: 5428480
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
    Castro O; Orlin J; Finch SC
    Yale J Biol Med; 1974 Mar; 47(1):55-60. PubMed ID: 4825087
    [No Abstract]   [Full Text] [Related]  

  • 4. Impaired antibody response to intravenous immunization in sickle cell anemia.
    Schwartz AD; Pearson HA
    Pediatr Res; 1972 Feb; 6(2):145-9. PubMed ID: 5065392
    [No Abstract]   [Full Text] [Related]  

  • 5. Sickle cell anemia: therapeutic considerations.
    Zarkowsky HS
    Heart Lung; 1974; 3(6):962-6. PubMed ID: 4140171
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatments for sickle cell disease.
    Med Lett Drugs Ther; 1973 Feb; 15(4):17-9. PubMed ID: 4695516
    [No Abstract]   [Full Text] [Related]  

  • 7. Extracorporeal treatment with cyanate in sickle cell disease: preliminary observations in four patients.
    Langer EE; Stamatoyannopoulos G; Hlastala MP; Adamson JW; Figley M; Labbe RF; Detter JC; Finch CA
    J Lab Clin Med; 1976 Mar; 87(3):462-74. PubMed ID: 1249477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolysis in sickle cell disease.
    Bensinger TA; Gillette PN
    Arch Intern Med; 1974 Apr; 133(4):624-31. PubMed ID: 4594397
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic-therapeutic ratio of sodium cyanate.
    Charache S; Duffy TP; Jander N; Scott JC; Bedine M; Morrell R
    Arch Intern Med; 1975 Aug; 135(8):1043-7. PubMed ID: 1156065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium cyanate as a potential treatment for sickle-cell disease.
    Gillette PN; Peterson CM; Lu YS; Cerami A
    N Engl J Med; 1974 Mar; 290(12):654-60. PubMed ID: 4813727
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical studies of a continuous extracorporeal cyanate treatment system for patients with sickle cell disease.
    Lee MY; Uvelli DA; Agodoa LC; Scribner BH; Finch CA; Babb AL
    J Lab Clin Med; 1982 Sep; 100(3):334-44. PubMed ID: 7108348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autotransfusion: a management option for alloimmunized sickle cell patients?
    Castro O
    Prog Clin Biol Res; 1982; 98():117-27. PubMed ID: 7146017
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatitis C seropositivity after multiple transfusions in sickle cell anemia patients in Yaounde, Cameroon].
    Kemmegne J; Bania D; Louis FJ
    Med Trop (Mars); 1996; 56(3):309-10. PubMed ID: 9026605
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia.
    Balcerzak SP; Grever MR; Sing DE; Bishop JN; Segal ML
    J Lab Clin Med; 1982 Sep; 100(3):345-55. PubMed ID: 7108349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia.
    Hulbert ML; Scothorn DJ; Panepinto JA; Scott JP; Buchanan GR; Sarnaik S; Fallon R; Chu JY; Wang W; Casella JF; Resar L; Berman B; Adamkiewicz T; Hsu LL; Smith-Whitley K; Mahoney D; Woods G; Watanabe M; DeBaun MR
    J Pediatr; 2006 Nov; 149(5):710-2. PubMed ID: 17095350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease--pathophysiology and treatment.
    Redding-Lallinger R; Knoll C
    Curr Probl Pediatr Adolesc Health Care; 2006; 36(10):346-76. PubMed ID: 17055417
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of patients attending sickle cell anaemia clinic, New Mulago Hospital, 1970-1971.
    Ndugwa CM; Kanyike FB
    East Afr Med J; 1973 Apr; 50(4):189-98. PubMed ID: 4730254
    [No Abstract]   [Full Text] [Related]  

  • 18. Principles and indications of chronic transfusion therapy for children with sickle cell disease.
    Ware R
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):686-8. PubMed ID: 17982409
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of sickle cell anemia patients].
    Bachir D; Galacteros F
    Rev Infirm; 1989 Oct; 39(16):35-40. PubMed ID: 2682977
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of two transfusion regimens in the perioperative management of children with sickle cell disease undergoing adenotonsillectomy.
    Wali YA; al Okbi H; al Abri R
    Pediatr Hematol Oncol; 2003; 20(1):7-13. PubMed ID: 12687748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.